Nuveen Real Asset Income and Growth Fund Announces Preliminary Results of Rights Offering
MWN-AI** Summary
Nuveen Real Asset Income and Growth Fund (NYSE: JRI) announced the preliminary results of its recent rights offering, which concluded on March 9, 2026. The offering allowed rights holders to subscribe for up to 7 million additional common shares at a subscription price of $12.40 per share, representing 90% of the Fund's net asset value on the Expiration Date. Following the rights offering, the Fund's Board approved a secondary oversubscription of an additional 1.75 million shares, bringing the total potential issuance to 8.75 million shares.
The offering was notably over-subscribed, with demand exceeding the available shares, prompting the allocation of shares on a pro-rata basis to those who fully exercised their rights. Investors with excess payments tied to their oversubscription requests will be refunded accordingly. The Fund anticipates that issued shares will be distributed by March 16, 2026, pending the completion of payments and allocations.
Nuveen, a well-regarded sponsor of closed-end funds with over $53 billion in assets under management as of December 31, 2025, focuses on income and alternative investments across various sectors, including real estate and infrastructure. With over 35 years of experience, Nuveen has built a reputation for delivering consistent income to investors.
Investors are advised to consider the Fund's investment objectives, risks, charges, and expenses before making an investment decision. The offering document does not constitute an offer of securities unless accompanied by a prospectus, which is available from the Fund's information agent. Investors are encouraged to review all relevant materials to understand the investment thoroughly.
MWN-AI** Analysis
The announcement of the preliminary results from the Nuveen Real Asset Income and Growth Fund's rights offering, which concluded on March 9, 2026, signals substantial investor interest and a proactive approach by the Fund's management. The approval of an aggregate total of 8,750,000 new common shares at a subscription price of $12.40—representing 90% of the net asset value—highlights a favorable entry point for both existing and potential investors.
The over-subscription of the offering is particularly noteworthy, indicating robust demand for the Fund's shares and confidence in its underlying asset management strategy. The pro-rata allocation of over-subscription shares suggests that investors are keen on securing additional exposure, reaffirming the attractiveness of Nuveen's investment thesis, which focuses on income generation through diversified real assets.
Investors considering an entry into JRI should be aware of the inherent risks associated with closed-end funds (CEFs), including their tendency to trade at discounts to net asset value (NAV). The current trading price, being significantly above the subscription price, may indicate a potential premium that investors will need to navigate moving forward.
Long-term investors should analyze the implications of this capital raise on the Fund’s liquidity and ability to pursue new investment opportunities. Additionally, with Nuveen's extensive history and expertise in managing a diverse range of investment vehicles, the Fund’s strategy may lean toward income-focused investors seeking regular returns in a fluctuating market.
However, it's essential to read the prospectus carefully to understand the investment objectives, risks, and charges associated with the Fund before committing capital. Monitoring the Fund's performance post-offering will be crucial, particularly post-share issuance expected by March 16, 2026, as this could influence market pricing dynamics and investor sentiment going forward.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Nuveen Real Asset Income and Growth Fund (NYSE: JRI) (the “Fund”) today announced the preliminary results of its transferable rights offering (the “Offer”) which expired at 5:00 p.m., Eastern time, on March 9, 2026 (the “Expiration Date”). The Offer entitled the rights holders to subscribe for an aggregate of up to an additional 7,000,000 common shares of the Fund (“Common Shares”). The Board has also approved a secondary over-subscription, whereby the Fund is authorized to increase the number of Common Shares to be issued by 1,750,000 Common Shares, for an aggregate total of 8,750,000 Common Shares.
The subscription price for the Common Shares to be issued was $12.40 per Common Share, which was equal to 90% of the Fund’s net asset value per Common Share at the close of trading on the NYSE on the Expiration Date. The gross proceeds of the Offer are expected to be approximately $108.5 million (including oversubscription requests and notices of guaranteed delivery).
The Offer was over-subscribed and the over-subscription requests exceeded the primary over-subscription and secondary over-subscription shares available. The available over-subscription shares will be allocated pro-rata among those fully exercising record date shareholders who over-subscribed based on the number of rights originally issued to them by the Fund. The Fund will return to those investors that submitted over-subscription requests the full amount of their excess payments.
The Common Shares subscribed for are expected to be issued on or about March 16, 2026, after receipt of all shareholder payments and completion of the pro-rata allocation of Common Shares with respect to the primary over-subscription privilege and the secondary over-subscription. The final subscription price is lower than the original estimated subscription price. Accordingly, any excess payments will be returned to subscribing rights holders as soon as practicable, in accordance with the prospectus supplement filed with the Securities and Exchange Commission on January 27, 2026.
This document is not an offer to sell any securities and is not soliciting an offer to buy any securities in any jurisdiction where the offer or sale is not permitted. This document is not an offering, which can only be made by a prospectus. Investors should consider the Fund’s investment objective, risks, charges and expenses carefully before investing. The Fund’s prospectus supplement and accompanying prospectus contain this and additional information about the Fund and additional information about the Offer, and should be read carefully before investing. To obtain the Fund’s prospectus supplement and accompanying prospectus, please contact the Fund’s information agent at 866-946-4206.
Nuveen is a leading sponsor of closed-end funds (CEFs) with $53 billion in assets under management across 44 CEFs as of 31 Dec 2025. The funds offer exposure to a broad range of asset classes and are designed for income-focused investors seeking regular distributions. Nuveen has more than 35 years of experience managing CEFs.
About Nuveen
Nuveen is a global investment leader, managing $1.4T in public and private assets for clients around the world, as of 31 Dec 2025. With broad expertise across income and alternatives, we invest in the growth of businesses, real estate, infrastructure, and natural capital, providing clients with the reliability, access, and foresight unique to our 125+ year heritage. Our prevailing perspective on the future drives our ambition to innovate and adapt our business to the changing needs of investors — all to pursue lasting performance for our clients, our communities, and our global economy. For more information, please visit www.nuveen.com . Nuveen Securities, LLC, member FINRA and SIPC.
The information contained on the Nuveen website is not a part of this press release.
Certain statements made in this release are forward-looking statements. Actual future results or occurrences may differ significantly from those anticipated in any forward-looking statements due to numerous factors. These include, but are not limited to:
- market developments;
- legal and regulatory developments; and
- other additional risks and uncertainties.
You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Nuveen and the closed-end funds managed by Nuveen and its affiliates undertake no responsibility to update publicly or revise any forward-looking statements.
The annual and semi-annual reports and other regulatory filings of Nuveen closed-end funds with the Securities and Exchange Commission (“SEC”) are accessible on the SEC’s web site at www.sec.gov and on Nuveen’s website at www.nuveen.com/cef and may discuss the above-mentioned or other factors that affect Nuveen closed-end funds.
Important information on risk
Past performance is no guarantee of future results. All investments carry a certain degree of risk, including the possible loss of principal, and there is no assurance that an investment will provide positive performance over any period of time. Certain products and services may not be available to all entities or persons. There is no guarantee that investment objectives will be achieved.
Closed-end funds frequently trade at a discount from net asset value (NAV). At any point in time, including when sold, shares may be worth more or less than the purchase price or the net asset value, even after considering the reinvestment of fund distributions. It is important to consider the objectives, risks, charges and expenses of any fund before investing.
5284946
View source version on businesswire.com: https://www.businesswire.com/news/home/20260310114522/en/
For more information, please visit Nuveen’s CEF homepage www.nuveen.com/closed-end-funds or contact:
Financial Professionals:
800-752-8700
Investors:
800-257-8787
Media:
media-inquiries@nuveen.com
FAQ**
What are the implications of the over-subscription in the Nuveen Real Asset Income and Growth Fund of Beneficial Interest JRI for future fundraising and shareholder confidence in the Fund's investment strategies?
How does the subscription price of $12.40 per Common Share compare to the historical performance of the Nuveen Real Asset Income and Growth Fund of Beneficial Interest JRI in terms of shareholder value?
What key risks should investors consider regarding the recent transferable rights offering of the Nuveen Real Asset Income and Growth Fund of Beneficial Interest JRI, especially in the context of market developments and regulatory changes?
How does the success of this rights offering position the Nuveen Real Asset Income and Growth Fund of Beneficial Interest JRI within the broader context of Nuveen's $1.asset management strategy and performance expectations?
**MWN-AI FAQ is based on asking OpenAI questions about Nuveen Real Asset Income and Growth Fund of Beneficial Interest (NYSE: JRI).
NASDAQ: JRI
JRI Trading
-1.42% G/L:
$12.7902 Last:
54,666 Volume:
$12.90 Open:
